People Who Use Drugs

The Latest

This Week in HIV Research: Better Serving the Underserved

May 9, 2019: HIV care retention and viral suppression among transgender women; heating opioid use equipment to curb HIV transmission; managing HIV outbreaks among people who are homeless; improving viral suppression among people who use substances.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Rethinking PrEP Guidelines

Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Do We Need New Statin Guidelines?

Cholesterol guidelines may underestimate statin value; shifting from Ryan White CARE Act to Affordable Care Act coverage; HCV seroconversion and CD4 count suppression; HCV reinfection odds by risk group.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Damming the Cascade of Unmet Needs

Unmet subsistence needs and clinical outcomes; finding HIV treatment success alongside quality-of-life issues; the potential value of facility-level HIV care continuum data; stimulant use and viral suppression.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: The Ubiquity, and Diversity, of Substance Use

Substance use rates among people with HIV; the continuing risk of PML; tenofovir gel efficacy and menopause; the cumulative cost of the global fight against HIV.

By Barbara Jungwirth and Myles Helfand

Phone Calls Key in Improving Retention in Higher-Risk Patients Living With HIV

An intervention to improve retention in HIV care had little impact on patients with depression or anxiety, alcohol use or drug use, in a 12-month study. However, among higher-risk patients who received at least 60% of intended intervention phone call...

By Mark Mascolini

Impact of Insurance, Depression, Drugs and Alcohol on Steady HIV Care

HIV-positive adults in King County, Washington -- where access to HIV care is virtually universal -- nevertheless often cited insurance or financial barriers as reasons for being out of care. Other factors included depression (detected in more than t...

By The Center for AIDS Information & Advocacy

Directly-Observed Therapy in HIV-Positive Heroin Users

Sixth International Congress on Drug Therapy in HIV Infection 17-21 November 2002, Glasgow, Scotland

Highly active antiretroviral therapy (HAART) in some injection drug users (IDUs) may be challenging for a number of reasons, some of which are:

r...

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

Nevirapine and Protease Inhibitor-Based Regimens in a Directly Observed Therapy (DOT) Program for Intravenous Drug Users

Nevirapine (NVP) and Protease Inhibitor (PI)-Based Regimens in a Directly Observed Therapy (DOT) Program for Intravenous Drug Users (IDUs) Abstract 545-T Authored by B. Conway1, J. Prasad1, R. Reynolds1, J. Farley1, N. Smith2, A. Meade2, an...

By Pablo Tebas, M.D.